Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Flotillin-2 dampens T cell antigen sensitivity and functionality
Sookjin Moon, Fei Zhao, Mohammad N. Uddin, Charles J. Tucker, Peer W.F. Karmaus, Michael B. Fessler
Sookjin Moon, Fei Zhao, Mohammad N. Uddin, Charles J. Tucker, Peer W.F. Karmaus, Michael B. Fessler
View: Text | PDF
Research Article Immunology

Flotillin-2 dampens T cell antigen sensitivity and functionality

  • Text
  • PDF
Abstract

T cell receptor (TCR) engagement triggers T cell responses, yet how TCR-mediated activation is regulated at the plasma membrane remains unclear. Here, we report that deleting the membrane scaffolding protein Flotillin-2 (Flot2) increases T cell antigen sensitivity, resulting in enhanced TCR signaling and effector function in response to weak TCR stimulation. T cell–specific Flot2-deficient mice exhibited reduced tumor growth and enhanced immunity to infection. Flot2-null CD4+ T cells exhibited increased Th1 polarization, proliferation, Nur77 induction, and phosphorylation of ZAP70 and ERK1/2 upon weak TCR stimulation, indicating a sensitized TCR-triggering threshold. Single-cell RNA-Seq suggested that Flot2-null CD4+ T cells follow a similar route of activation as WT CD4+ T cells but exhibit higher occupancy of a discrete activation state under weak TCR stimulation. Given prior reports that TCR clustering influences sensitivity of T cells to stimuli, we evaluated TCR distribution with super-resolution microscopy. Flot2 ablation increased the number of surface TCR nanoclusters on naive CD4+ T cells. Collectively, we posit that Flot2 modulates T cell functionality to weak TCR stimulation, at least in part, by regulating surface TCR clustering. Our findings have implications for improving T cell reactivity in diseases with poor antigenicity, such as cancer and chronic infections.

Authors

Sookjin Moon, Fei Zhao, Mohammad N. Uddin, Charles J. Tucker, Peer W.F. Karmaus, Michael B. Fessler

×

Figure 6

Flot2 ablation sensitizes TCR triggering threshold in CD4+ T cells.

Options: View larger image (or click on image) Download as PowerPoint
Flot2 ablation sensitizes TCR triggering threshold in CD4+ T cells.
(A–C...
(A–C) Naive CD4+ T cells were stimulated in vitro for 3 hours (B) or 24 hours (C) with varying doses of plate-bound αCD3, alongside a fixed dose of soluble αCD28 (1 μg/mL), followed by FACS. Representative plots (A) show Nur77+ (B) and CD69+ (C) populations within viable TCRβ+CD4+ population. (D–G) Western blot of the phosphorylation of TCR signaling molecules in naive CD4+ T cells stimulated with varying doses of plate-bound αCD3 for 3 minutes. Representative blots (D) and quantifications of pZAP70 (E), pERK1/2 (F), and pLck (Y505) (G), normalized to their respective total protein levels (ZAP70, ERK1/2, and Lck), are shown. (H and I) scRNA-Seq was performed on naive CD4+ T cells following a 3-hour stimulation with varying concentrations of plate-bound αCD3. A fixed dose of soluble αCD28 (1 μg/mL) was provided under the conditions of 0.25 or 1 μg/mL of plate-bound αCD3. Unsupervised T cell clusters were annotated as 5 distinguishable functional states on a UMAP plot (H), and the effect of stimulation dose was projected onto the UMAP (I). (J) Distribution of Flot2WT or Flot2CD4 CD4+ T cells in each cluster. Red arrows indicate the priming clusters for each genotype. (K) Occupancy of Flot2WT or Flot2CD4 genotype in each T cell cluster, analyzed by total or each stimulatory condition. (L) Volcano plots of spliced RNA in naive, priming, and activated clusters. (M) Expression level of spliced RNA related to cellular proliferation in the naive cluster. Data are pooled from 3 (A–C), 5 (E), 8 (F), or 7 (G) independent experiments. Data were analyzed by 1-way ANOVA followed with Šidák’s multiple-comparison tests (B, C, and E–G), χ2 analysis (K), or Wilcoxon ranked-sum test (M). Data are shown as mean ± SEM; *P < 0.05; **P < 0.01; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts